Development-Driven M&A Marks The Vaccines Market

When GlaxoSmithKline acquired Swiss company Okairos AG for 250 million euros ($325 million), GSK’s objective was to enable it to develop vaccines in-house; similarly, when CSL acquired the influenza vaccine business of Novartis, a much bigger company and when, in November 2016, Eagle Pharmaceuticals acquired Arsia Therapeutics, another relatively small pharma business, for $30 million.

The global biologics market is fairly concentrated, with ten companies accounting for over 80% of sales. The US’s Johnson & Johnson is in the lead, closely followed by Swiss company Hoffman-La Raoche. Bristol-Myers Squibb, Glaxo Smith-Kline and AbbVie Inc. are other key players.  All the same, consolidation, rationalization and development-driven M&A are major trends in the biologics industry.

Download a sample of the report at

https://www.thebusinessresearchcompany.com/sample.aspx?id=774&type=smp

North America is the leading region for both biologic and other pharma sales but the story is different in second and third place. Asia Pacific has overtaken Western Europe in small-molecule drug sales but in biologics, Western Europe is still well ahead of Asia Pacific. The high cost of biologics, making them more affordable in affluent Western Europe, the greater prevalence there of the age-related diseases that many current biologics are designed to treat, and the more rapid growth of the biosimilars market in Asia Pacific account for this difference.

The USA’s biologics market is by far the world’s largest, worth seven times that of the second largest, Japan. Growth, however is widespread, with the BRICs (Brazil, Russia, India and China) in the lead. For instance, growth in India’s tiny market has surged recently, from the 12.4% CAGR it was achieving up to 2017, to 21%. Growth has also accelerated in the European markets – the UK, France, Spain, German and Italy are all now seeing double-digit growth, as is the otherwise often somnolent market of Japan. Growth in the US market, though a little slower in percentages, is of course worth most in dollars.

Where To Learn More

Read the Biologics Global Market Report 2018 from The Business Research Company for information on the following:

Markets Covered: Biologics,healthcare services, pharmaceutical drugs, medical equipment.

Biologics Market Companies Covered: Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, GlaxoSmithKline Plc., AbbVie, Amgen, Sanofi S.A., Eli Lilly and Company, Merck & Co., Pfizer

Regions: North America, Asia Pacific, Western Europe, South America, Eastern Europe, Middle East, Africa.

Countries: USA, China, UK, Japan, France, Germany, Australia, India, Spain, Russia, Italy, Brazil

Time Series: Five years historic (2013-17) and forecast (2017-21).

Data Segmentations: Biologics market historic and forecast size and growth rates for the world, 7 regions and 12 countries, therapeutic proteins, monoclonal antibodies (MAbS), and vaccines segments historic and forecast size, segment share, and growth rates for the world, 7 regions and 12 countries, global competitor sales and market shares.  

Healthcare market segment shares for the world, 7 regions and 12 countries.

Other Data: Per capita average biologics expenditure, global and by country, biologics market size as a percentage of GDP across countries, biologics and biosimilars drugs sales proportion, number of general practitioners for 12 countries.

Other Information: Drivers and restraints of the global biologics market, PESTEL analysis, company profiles including products, strategy and financial performance for 10 biologics companies, biologics market trends and strategies, biologics market key mergers and acquisitions

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes. Sources include primary as well as extensive secondary research.

Number of Figures in the report: 84

Number of Tables in the report: 82

Interested to know more? Here is a list of reports similar to “Biologics Global Market Report 2018”:

Pharmaceutical Drugs Global Market Report 2018

Bio-Pharmaceutical Logistics Global Market Report 2018

Table of Contents

Executive Summary……………………………………………………………………………………………………………………………… 17

Biologics Market Characteristics…………………………………………………………………………………………………………….. 18

Market Overview…………………………………………………………………………………………………………………………….. 18

Market Segmentation……………………………………………………………………………………………………………………….. 20

Market Value Chain………………………………………………………………………………………………………………………….. 22

Biologics Market Size And Growth………………………………………………………………………………………………………….. 24

Biologics Historic Market Growth………………………………………………………………………………………………………… 24

Drivers Of The Market………………………………………………………………………………………………………………………. 25

Restraints On The Market………………………………………………………………………………………………………………….. 26

Biologics Market Forecast Growth……………………………………………………………………………………………………….. 27

Drivers Of The Market………………………………………………………………………………………………………………………. 28

Increase In Healthcare Access………………………………………………………………………………………………………….. 28

Restraints On The Market………………………………………………………………………………………………………………….. 29

PESTLE Analysis…………………………………………………………………………………………………………………………………… 30

Political………………………………………………………………………………………………………………………………………. 31

Economic……………………………………………………………………………………………………………………………………. 31

Social…………………………………………………………………………………………………………………………………………. 31

Technological………………………………………………………………………………………………………………………………. 32

Legal………………………………………………………………………………………………………………………………………….. 32

Environmental……………………………………………………………………………………………………………………………… 32

Biologics Market Segmentation……………………………………………………………………………………………………………… 33

Global Biologics Market, 2017, Split By Segments, $ Billion……………………………………………………………………….. 33

Monoclonal Antibodies (mAbs)……………………………………………………………………………………………………….. 34

Therapeutic Proteins…………………………………………………………………………………………………………………….. 34

Vaccines……………………………………………………………………………………………………………………………………… 34

Global Biologics Market, Historic and Forecast Growth Rates, Split By Segments, 2013-2021…………………………… 35

Global Biologics Market Trends And Strategies………………………………………………………………………………………….. 36

Demand For Biologics In The Treatment Of Complex Diseases…………………………………………………………………… 36

Development And Increasing Demand For Next Generation Biologics…………………………………………………………. 36

Revised FDA Regulations To Facilitate Biologics Drug Development……………………………………………………………. 37

Higher Profit Margins For Biologics……………………………………………………………………………………………………… 37

Higher Investments………………………………………………………………………………………………………………………….. 37

Global Biologics Market Compared With Similar Markets, 2017…………………………………………………………………….. 38

Healthcare Market Segmentation, By Region, 2017……………………………………………………………………………… 38

Healthcare Market Segmentation, By Country, 2017……………………………………………………………………………. 39

Global Biologics Market Segment Details………………………………………………………………………………………………. 41

Monoclonal Antibodies (mAbs)…………………………………………………………………………………………………………… 41

Monoclonal Antibodies Market Characteristics…………………………………………………………………………………… 41

Global Monoclonal Antibodies Market, 2017, By Source……………………………………………………………………….. 41

Global Monoclonal Antibodies Market, 2017, By Therapeutic Area………………………………………………………….. 43

Monoclonal Antibodies Market Trends And Strategies………………………………………………………………………….. 45

Therapeutic Proteins………………………………………………………………………………………………………………………… 46

Therapeutic Proteins Market Characteristics………………………………………………………………………………………. 46

Global Therapeutic Proteins Market, 2017, By Type……………………………………………………………………………… 46

Global Therapeutic Proteins Market, 2017, By Therapeutic Area…………………………………………………………….. 47

Therapeutic Proteins Market Trends And Strategies…………………………………………………………………………….. 49

Vaccines………………………………………………………………………………………………………………………………………… 50

Vaccines Market Characteristics………………………………………………………………………………………………………. 50

Global Vaccines Market, 2017, By End User………………………………………………………………………………………… 50

Global Vaccines Market, 2017, By Therapeutic Area…………………………………………………………………………….. 51

Vaccines Market Trends And Strategies…………………………………………………………………………………………….. 53

Biologics Market Geography Regional and Country Analysis…………………………………………………………………………. 54

Biologics Market, 2017, By Region……………………………………………………………………………………………………….. 54

Biologics Market, Historic And Forecast Growth Rates, Split By Region, 2013-2021………………………………………… 56

Biologics Market, Split By Country, 2017…………………………………………………………………………………………….58

Biologics Market, Historic And Forecast Growth Rates, Split By Country, 2013-2021………………………………………..60

Global Biologics Market Comparison With Macro Economic Factors………………………………………………………………. 62

Biologics Market Size, Percentage Of GDP, Global…………………………………………………………………………………… 62

Per Capita Average Biologics Expenditure, Global…………………………………………………………………………………… 63

Biologics Market Comparison With Macro Economic Factors Across Countries…………………………………………………. 64

Biologics Market Size, Percentage of GDP, By Country……………………………………………………………………………… 64

Per Capita Average Biologics Expenditure, By Country……………………………………………………………………………… 65

Biologics Market Comparison With Industry Metrics…………………………………………………………………………………… 66

Biologics & Biosimilars Sales Proportion By Country (Value), 2017, By Country……………………………………………… 66

Global Biologics Under Development, 2017…………………………………………………………………………………………… 68

New Biologics Approvals, 2017…………………………………………………………………………………………………………… 69

Number Of General Practitioners 2016, By Country………………………………………………………………………………… 70

Average Revenue Per General Practitioner 2016, By Country…………………………………………………………………….. 71

Biologics Market Regional And Country Analysis………………………………………………………………………………………… 72

Asia-Pacific Biologics Market…………………………………………………………………………………………………………………. 72

Asia-Pacific Biologics Market Overview…………………………………………………………………………………………………. 72

Region Information……………………………………………………………………………………………………………………….. 72

General Information……………………………………………………………………………………………………………………… 72

Government Initiatives………………………………………………………………………………………………………………….. 72

Regulations…………………………………………………………………………………………………………………………………. 73

Regulatory Bodies…………………………………………………………………………………………………………………………. 73

Investments………………………………………………………………………………………………………………………………… 73

Associations………………………………………………………………………………………………………………………………… 74

Competitive Landscape………………………………………………………………………………………………………………….. 74

Asia Pacific Biologics Market………………………………………………………………………………………………………………. 74

Asia-Pacific Biologics Historic Market, 2013-2017……………………………………………………………………………………. 74

Asia-Pacific Biologics Forecast Market, 2017-2021………………………………………………………………………………….. 75

Asia-Pacific Biologics Market, 2017, By Segment…………………………………………………………………………………….. 76

Asia-Pacific Biologics Market: Country Analysis………………………………………………………………………………………. 78

China Biologics Market Overview………………………………………………………………………………………………………… 78

Country Information……………………………………………………………………………………………………………………… 78

General Information……………………………………………………………………………………………………………………… 78

Government Initiatives………………………………………………………………………………………………………………….. 78

Regulations…………………………………………………………………………………………………………………………………. 78

Regulatory Bodies…………………………………………………………………………………………………………………………. 78

Investments………………………………………………………………………………………………………………………………… 78

Associations………………………………………………………………………………………………………………………………… 79

Competitive Landscape………………………………………………………………………………………………………………….. 79

China Biologics Market……………………………………………………………………………………………………………………… 79

China Biologics Historic Market, 2013-2017…………………………………………………………………………………………… 80

China Biologics Forecast Market, 2017-2021………………………………………………………………………………………….. 81

China Biologics Market, 2017, By Segment……………………………………………………………………………………………. 82

India Biologics Market Overview…………………………………………………………………………………………………………. 83

Country Information……………………………………………………………………………………………………………………… 83

General Information……………………………………………………………………………………………………………………… 83

Government Initiatives………………………………………………………………………………………………………………….. 83

Regulations…………………………………………………………………………………………………………………………………. 83

Regulatory Bodies…………………………………………………………………………………………………………………………. 84

Investments………………………………………………………………………………………………………………………………… 84

Associations………………………………………………………………………………………………………………………………… 84

Competitive Landscape………………………………………………………………………………………………………………….. 84

India Biologics Market………………………………………………………………………………………………………………………. 85

India Biologics Historic Market, 2013-2017……………………………………………………………………………………………. 85

India Biologics Forecast Market, 2017-2021…………………………………………………………………………………………… 86

India Biologics Market, 2017, By Segment…………………………………………………………………………………………….. 87

Japan Biologics Market Overview………………………………………………………………………………………………………… 88

Country Information……………………………………………………………………………………………………………………… 88

General Information……………………………………………………………………………………………………………………… 88

Government Initiatives………………………………………………………………………………………………………………….. 88

Regulations…………………………………………………………………………………………………………………………………. 88

Regulatory Bodies…………………………………………………………………………………………………………………………. 88

Investments………………………………………………………………………………………………………………………………… 88

Associations………………………………………………………………………………………………………………………………… 89

Competitive Landscape………………………………………………………………………………………………………………….. 89

Japan Biologics Market……………………………………………………………………………………………………………………… 89

Japan Biologics Historic Market, 2013-2017…………………………………………………………………………………………… 89

Japan Biologics Forecast Market, 2017-2021………………………………………………………………………………………….. 90

Japan Biologics Market, 2017, By Segment……………………………………………………………………………………………. 91

Australia Biologics Market Overview……………………………………………………………………………………………………. 93

Country Information……………………………………………………………………………………………………………………… 93

General Information……………………………………………………………………………………………………………………… 93

Government Initiatives………………………………………………………………………………………………………………….. 93

Regulations…………………………………………………………………………………………………………………………………. 93

Australia Biologics Market…………………………………………………………………………………………………………………. 93

Australia Biologics Historic Market, 2013-2017………………………………………………………………………………………. 94

Australia Biologics Forecast Market, 2017-2021……………………………………………………………………………………… 95

Australia Biologics Market, 2017, By Segment………………………………………………………………………………………… 96

Western Europe Biologics Market…………………………………………………………………………………………………………… 97

Western Europe Biologics Market Overview………………………………………………………………………………………….. 97

Region Information……………………………………………………………………………………………………………………….. 97

General Information……………………………………………………………………………………………………………………… 97

Government Initiatives………………………………………………………………………………………………………………….. 97

Regulations…………………………………………………………………………………………………………………………………. 97

Regulatory Bodies…………………………………………………………………………………………………………………………. 98

Investments………………………………………………………………………………………………………………………………… 98

Associations………………………………………………………………………………………………………………………………… 99

Competitive Landscape………………………………………………………………………………………………………………….. 99

Western Europe Biologics Market……………………………………………………………………………………………………… 100

Western Europe Biologics Historic Market, 2013-2017…………………………………………………………………………… 100

Western Europe Biologics Forecast Market, 2017-2021………………………………………………………………………….. 101

Western Europe Biologics Market, 2017, By Segment…………………………………………………………………………….. 103

Western Europe Biologics Market: Country Analysis………………………………………………………………………………. 104

UK Biologics Market Overview………………………………………………………………………………………………………….. 104

Country Information……………………………………………………………………………………………………………………. 104

General Information……………………………………………………………………………………………………………………. 104

Government Initiatives…………………………………………………………………………………………………………………. 104

Regulations……………………………………………………………………………………………………………………………….. 104

Regulatory Bodies……………………………………………………………………………………………………………………….. 104

Investments……………………………………………………………………………………………………………………………….. 104

Associations………………………………………………………………………………………………………………………………. 105

Competitive Landscape………………………………………………………………………………………………………………… 105

UK Biologics Market……………………………………………………………………………………………………………………….. 106

UK Biologics Historic Market, 2013-2017…………………………………………………………………………………………….. 106

UK Biologics Forecast Market, 2017-2021……………………………………………………………………………………………. 107

UK Biologics Market, 2017, By Segment………………………………………………………………………………………………. 108

Germany Biologics Market Overview………………………………………………………………………………………………….. 109

Country Information……………………………………………………………………………………………………………………. 109

General Information……………………………………………………………………………………………………………………. 109

Government Initiatives…………………………………………………………………………………………………………………. 109

Regulations……………………………………………………………………………………………………………………………….. 109

Regulatory Bodies……………………………………………………………………………………………………………………….. 109

Investments……………………………………………………………………………………………………………………………….. 109

Associations………………………………………………………………………………………………………………………………. 110

Competitive Landscape………………………………………………………………………………………………………………… 110

Germany Biologics Market……………………………………………………………………………………………………………….. 111

Germany Biologics Historic Market, 2013-2017…………………………………………………………………………………….. 111

Germany Biologics Forecast Market, 2017-2021……………………………………………………………………………………. 112

Germany Biologics Market, 2017, By Segment……………………………………………………………………………………… 113

France Biologics Market Overview……………………………………………………………………………………………………… 114

Country Information……………………………………………………………………………………………………………………. 114

General Information……………………………………………………………………………………………………………………. 114

Government Initiatives…………………………………………………………………………………………………………………. 114

Regulations……………………………………………………………………………………………………………………………….. 114

Regulatory Bodies……………………………………………………………………………………………………………………….. 114

Investments……………………………………………………………………………………………………………………………….. 114

Associations………………………………………………………………………………………………………………………………. 115

Competitive Landscape………………………………………………………………………………………………………………… 115

France Biologics Market…………………………………………………………………………………………………………………… 116

France Biologics Historic Market, 2013-2017………………………………………………………………………………………… 116

France Biologics Forecast Market, 2017-2021………………………………………………………………………………………. 117

France Biologics Market, 2017, By Segment…………………………………………………………………………………………. 118

Italy Biologics Market Overview………………………………………………………………………………………………………… 119

Country Information……………………………………………………………………………………………………………………. 119

General Information……………………………………………………………………………………………………………………. 119

Regulations……………………………………………………………………………………………………………………………….. 119

Regulatory Bodies……………………………………………………………………………………………………………………….. 119

Investments……………………………………………………………………………………………………………………………….. 119

Competitive Landscape………………………………………………………………………………………………………………… 119

Italy Biologics Market……………………………………………………………………………………………………………………… 121

Italy Biologics Historic Market, 2013-2017…………………………………………………………………………………………… 121

Italy Biologics Forecast Market, 2017-2021………………………………………………………………………………………….. 122

Italy Biologics Market, 2017, By Segment…………………………………………………………………………………………….. 123

Spain Biologics Market Overview……………………………………………………………………………………………………….. 124

Country Information……………………………………………………………………………………………………………………. 124

General Information……………………………………………………………………………………………………………………. 124

Government Initiatives…………………………………………………………………………………………………………………. 124

Regulations……………………………………………………………………………………………………………………………….. 124

Regulatory Bodies……………………………………………………………………………………………………………………….. 124

Associations………………………………………………………………………………………………………………………………. 124

Competitive Landscape………………………………………………………………………………………………………………… 124

Spain Biologics Market…………………………………………………………………………………………………………………….. 125

Spain Biologics Historic Market, 2013-2017…………………………………………………………………………………………. 125

Spain Biologics Forecast Market, 2017-2021………………………………………………………………………………………… 126

Spain Biologics Market, 2017, By Segment…………………………………………………………………………………………… 127

Eastern Europe Biologics Market…………………………………………………………………………………………………………… 128

Eastern Europe Biologics Market Overview………………………………………………………………………………………….. 128

Region Information……………………………………………………………………………………………………………………… 128

General Information……………………………………………………………………………………………………………………. 128

Government Initiatives…………………………………………………………………………………………………………………. 128

Regulations……………………………………………………………………………………………………………………………….. 128

Regulatory Bodies……………………………………………………………………………………………………………………….. 128

Investments……………………………………………………………………………………………………………………………….. 128

Associations………………………………………………………………………………………………………………………………. 128

Competitive Landscape………………………………………………………………………………………………………………… 128

Eastern Europe Biologics Market……………………………………………………………………………………………………….. 129

Eastern Europe Biologics Historic Market, 2013-2017…………………………………………………………………………….. 129

Eastern Europe Biologics Forecast Market, 2017-2021……………………………………………………………………………. 130

Eastern Europe Biologics Market, 2017, By Segment……………………………………………………………………………… 131

Russia Biologics Market Overview……………………………………………………………………………………………………… 132

Country Information……………………………………………………………………………………………………………………. 132

General Information……………………………………………………………………………………………………………………. 132

Government Initiatives…………………………………………………………………………………………………………………. 132

Regulations……………………………………………………………………………………………………………………………….. 132

Regulatory Bodies……………………………………………………………………………………………………………………….. 132

Investments……………………………………………………………………………………………………………………………….. 132

Associations………………………………………………………………………………………………………………………………. 132

Competitive Landscape………………………………………………………………………………………………………………… 132

Russia Biologics Market…………………………………………………………………………………………………………………… 132

Russia Biologics Historic Market, 2013-2017………………………………………………………………………………………… 133

Russia Biologics Forecast Market, 2017-2021……………………………………………………………………………………….. 134

Russia Biologics Market, 2017, By Segment………………………………………………………………………………………….. 135

North America Biologics Market……………………………………………………………………………………………………………. 136

North America Biologics Market Overview…………………………………………………………………………………………… 136

Region Information……………………………………………………………………………………………………………………… 136

General Information……………………………………………………………………………………………………………………. 136

Regulations……………………………………………………………………………………………………………………………….. 136

Regulatory Bodies……………………………………………………………………………………………………………………….. 136

Investments……………………………………………………………………………………………………………………………….. 137

Competitive Landscape………………………………………………………………………………………………………………… 137

North America Biologics Market………………………………………………………………………………………………………… 137

North America Biologics Historic Market, 2013-2017……………………………………………………………………………… 137

North America Biologics Forecast Market, 2017-2021……………………………………………………………………………. 138

North America Biologics Market, 2017, By Segment………………………………………………………………………………. 140

North America Biologics Market: Country Analysis………………………………………………………………………………… 141

USA Biologics Market Overview…………………………………………………………………………………………………………. 141

Country Information……………………………………………………………………………………………………………………. 141

General Information……………………………………………………………………………………………………………………. 141

Regulations……………………………………………………………………………………………………………………………….. 141

Regulatory Bodies……………………………………………………………………………………………………………………….. 141

Investments……………………………………………………………………………………………………………………………….. 141

Competitive Landscape………………………………………………………………………………………………………………… 141

USA Biologics Market………………………………………………………………………………………………………………………. 141

USA Biologics Historic Market, 2013-2017…………………………………………………………………………………………… 142

USA Biologics Forecast Market, 2017-2021………………………………………………………………………………………….. 144

USA Biologics Market, 2017, By Segment…………………………………………………………………………………………….. 145

South America Biologics Market……………………………………………………………………………………………………………. 146

South America Biologics Market Overview…………………………………………………………………………………………… 146

Region Information……………………………………………………………………………………………………………………… 146

General Information……………………………………………………………………………………………………………………. 146

Government Initiatives…………………………………………………………………………………………………………………. 146

Regulations……………………………………………………………………………………………………………………………….. 146

Regulatory Bodies……………………………………………………………………………………………………………………….. 146

Associations………………………………………………………………………………………………………………………………. 146

Competitive Landscape………………………………………………………………………………………………………………… 146

South America Biologics Market………………………………………………………………………………………………………… 147

South America Biologics Historic Market, 2013-2017……………………………………………………………………………… 147

South America Biologics Forecast Market, 2017-2021……………………………………………………………………………. 148

South America Biologics Market, 2017, By Segment………………………………………………………………………………. 149

South America Biologics Market: Country Analysis………………………………………………………………………………… 151

Brazil Biologics Market Overview……………………………………………………………………………………………………….. 151

Country Information……………………………………………………………………………………………………………………. 151

General Information……………………………………………………………………………………………………………………. 151

Government Initiatives…………………………………………………………………………………………………………………. 151

Regulations……………………………………………………………………………………………………………………………….. 151

Regulatory Bodies……………………………………………………………………………………………………………………….. 151

Associations………………………………………………………………………………………………………………………………. 151

Competitive Landscape………………………………………………………………………………………………………………… 151

Brazil Biologics Market……………………………………………………………………………………………………………………. 152

Brazil Biologics Historic Market, 2013-2017…………………………………………………………………………………………. 152

Brazil Biologics Forecast Market, 2017-2021………………………………………………………………………………………… 153

Brazil Biologics Market, 2017, By Segment…………………………………………………………………………………………… 154

Middle East Biologics Market……………………………………………………………………………………………………………….. 155

Middle East Biologics Market Overview………………………………………………………………………………………………. 155

Region Information……………………………………………………………………………………………………………………… 155

General Information……………………………………………………………………………………………………………………. 155

Regulations……………………………………………………………………………………………………………………………….. 155

Regulatory Bodies……………………………………………………………………………………………………………………….. 155

Investments……………………………………………………………………………………………………………………………….. 155

Competitive Landscape………………………………………………………………………………………………………………… 155

Middle East Biologics Market……………………………………………………………………………………………………………. 156

Middle East Biologics Historic Market, 2013-2017…………………………………………………………………………………. 156

Middle East Biologics Forecast Market, 2017-2021………………………………………………………………………………… 157

Middle East Biologics Market, 2017, By Segment………………………………………………………………………………….. 159

Africa Biologics Market……………………………………………………………………………………………………………………….. 160

Africa Biologics Market Overview………………………………………………………………………………………………………. 160

Region Information……………………………………………………………………………………………………………………… 160

General Information……………………………………………………………………………………………………………………. 160

Regulations……………………………………………………………………………………………………………………………….. 160

Regulatory Bodies……………………………………………………………………………………………………………………….. 160

Investments……………………………………………………………………………………………………………………………….. 161

Associations………………………………………………………………………………………………………………………………. 161

Competitive Landscape………………………………………………………………………………………………………………… 161

Africa Biologics Market……………………………………………………………………………………………………………………. 162

Africa Biologics Historic Market, 2013-2017…………………………………………………………………………………………. 162

Africa Biologics Forecast Market, 2017-2021………………………………………………………………………………………… 163

Africa Biologics Market, 2017, By Segment………………………………………………………………………………………….. 164

The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 207 1930 708
Address:47 Anchorage Point, 42 Cuba Street, Canary Wharf
Country: United Kingdom
Website: www.thebusinessresearchcompany.com